NEWPHARMA GROUP
Actief
0684.465.652 - 4020 Liège
People administring NEWPHARMA GROUP
Name | Role / Mandate | Year |
---|---|---|
- Colpaert Dries Colfima SPRL | Vertegenwoordiger | 2019 |
Cédric Antonelli | Vertegenwoordiger | 2021, 2020, 2019 |
Didier Struye | Vertegenwoordiger | 2019 |
Dieter STRUYE | Vertegenwoordiger | 2020 |
Dries COLPAERT | Vertegenwoordiger | 2021, 2020 |
Jérôme GOBBESSO | Vertegenwoordiger | 2021, 2020, 2019 |
Marc HOFMAN | Vertegenwoordiger | 2021 |
Olivier Witmeur | Vertegenwoordiger | 2021, 2020, 2019 |
Thomas De Kempeneer | Vertegenwoordiger | 2021, 2020, 2019 |
Companies administring NEWPHARMA GROUP
Name | Enterprise # | Role | Year |
---|---|---|---|
BDO BEDRIJFSREVISOREN SCRL | 0431.088.289 | Commissaris | 2020, 2019 |
BDO BEDRIJFSREVISOREN SRL | 0431.088.289 | Commissaris | 2021 |
ETABLISSEMENT FRANZ COLRUYT SA | 0400.378.485 | Bestuurder | 2021, 2020 |
ETABLISSEMENT FRANZ CORLUYT SA | 0400.378.485 | Bestuurder | 2019 |
JGO SPRL | 0643.915.001 | Gedelegeerd bestuurder | 2019 |
JGO SRL | 0643.915.001 | Gedelegeerd bestuurder | 2021, 2020 |
KORYS BUSINESS SERVICES SA | 0418.759.787 | Voorzitter van de Raad van Bestuur | 2021, 2020, 2019 |
KORYS MANAGEMENT SA | 0885.971.571 | Bestuurder | 2021, 2020, 2019 |
OMCR SPRL | 0453.412.840 | Bestuurder | 2019 |
OMCR SRL | 0453.412.840 | Bestuurder | 2021, 2020 |
Companies that are administered by NEWPHARMA GROUP
Name | Enterprise # | Role | Year |
---|---|---|---|
NEWPHARMA | 0838.666.156 | Moederonderneming | 2021,2019,2020,2018 |
MegaPharma | 0836.216.610 | Moederonderneming | 2019,2021,2020,2018 |
Companies holding participations in NEWPHARMA GROUP
Participations in | Value | Amount | % Direct | % Indirect | Type |
---|---|---|---|---|---|
KORYS INVESTMENTS | KORYS INVESTMENTS | 0871.963.979 | Shareholder | ||
ETABLISSEMENTEN FRANZ COLRUYT | ETABLISSEMENTEN FRANZ COLRUYT | 0400.378.485 | Shareholder |
NEWPHARMA GROUP has participations in
Participations in | Value | Amount | % Direct | % Indirect | Type |
---|---|---|---|
No data available |